Honey’s Potential to Save Lives Wednesday, February 10, 2016 The healing powers of honey have been known for thousands of years. Muscles on-a-Chip Wednesday, February 10, 2016 This study may help explain why stem cell-based therapies have so far shown limited benefits for heart attack patients in clinical trials.3-D Printed Lifelike Liver Tissue for Drug Screening Wednesday, February 10, 2016 A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling. Ocean Acidification Makes Coralline Algae Less Robust Wednesday, February 10, 2016 Ocean acidification (the ongoing decrease in the pH of the Earth’s oceans, caused by the uptake of CO2 from the atmosphere), is affecting the formation of the skeleton of coralline algae which play an important part in marine biodiversity, new research from the University of Bristol has found.Genetically Mapping the Most Lethal E.Coli Strains Wednesday, February 10, 2016 New approach could lead to fewer deaths, and new treatments. VBI, GSK Collaborate Wednesday, February 10, 2016 VBI Vaccines has entered into a research collaboration with GlaxoSmithKline Biologicals SA (“GSK”) to evaluate VBI’s LPV™ Platform. VBI’s LPV Platform is a proprietary formulation and process that enables the development of vaccines and biologics with improved stability and preserved potency.A Quantitative View of Flexible Electronics Wednesday, February 10, 2016 The latest Olympus application note details how observing in situ mechanical testing of flexible electronic devices with the Olympus LEXT OLS4100 confocal laser scanning microscope is providing valuable quantitative information for optimising interconnect design. Preparing for Potential Zika Outbreaks Wednesday, February 10, 2016 Experts at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) are developing tools to monitor the spread of the Zika virus and are conducting research to gather more solid data to better assess the risks associated with the infection. Quotient Clinical Celebrates its 100th RapidFACT® Program Wednesday, February 10, 2016 Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has completed its 100th RapidFACT (Rapid Formulation development And Clinical Testing) program – a significant milestone in the growth of this service, which addresses drug R&D productivity issues.